Typhoid Antibody Testing Market Growth Drivers and Challenges:
Growth Drivers
- Increased Rate of Morbidity and Mortality – Typhoid is a deadly disease that can kill people at the same time a wide number of people get affected by it. According to the data from the World Health Organization (WHO), around 11 – 20 million people are known to have typhoid disease. In this, between 128,000 and 161,000 people are known to die as a result of the disease every year.
- Government Support to Manage Typhoid Cases – Government authorities in developing countries are supporting initiatives that promote proper sanitization. Developing countries or underdeveloped countries don’t have proper sanitization. Government authorities of the regions have introduced various programs and initiatives for proper sanitization to support the management of typhoid cases. For instance, the “Swachh Bharat Mission” program was initiated by the Indian government and aims to improve sanitation conditions and waste management, as well as the construction of community toilets throughout the country by 2019.
- Increased Collaboration among the Market Players – Several companies have gone through mergers and acquisitions to expand their product portfolios and increase their market share. Growing merger collaboration among the market players is expected to drive the growth of the typhoid antibody testing market in the future. For instance, in 2020 Abbott Laboratories acquired Alere Inc.'s diagnostics business. This included a range of products to test for typhoid antibodies.
Challenges
- Lacking Early Diagnosis of Enteric Symptoms – In 90% of cases it is seen that patients who are suffering from typhoid never get it diagnosed at an early age of symptoms. This is seen highly in Asia Pacific countries.
- Lack of Awareness Related to Antibody Testing Kits
- Patient’s Exposure to Other Antibiotics Before Visiting Healthcare Facility
Typhoid Antibody Testing Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
8.2% |
|
Base Year Market Size (2025) |
USD 8.42 billion |
|
Forecast Year Market Size (2035) |
USD 18.52 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of typhoid antibody testing is assessed at USD 9.04 billion.
The global typhoid antibody testing market size was valued at over USD 8.42 billion in 2025 and is expected to expand at a CAGR of around 8.2%, surpassing USD 18.52 billion revenue by 2035.
Asia Pacific typhoid antibody testing market will hold around 41% share by 2035, driven by increasing typhoid cases and government-led awareness initiatives.
Key players in the market include IDL Biotech AB, LINEAR CHEMICALS, S.L.U, Medical Innovation Ventures Sdn Bhd, Thermo Fisher Scientific, Nectar Lifesciences Ltd., DIALAB GmbH., BIOSYSTEMS S.A., Siemens Healthcare GmbH, NanoEnTek, CerTest Biotec S.L.